On Sept. 30, 2020, researchers from the Perelman School of Medicine reported results from a clinical trial testing whether a daily regimen of hydroxychloroquine could protect those most likely to be exposed to COVID-19, The results found there was no difference in infection rates among health care workers who took the drug versus those taking a placebo. The study was published today in JAMA Internal Medicine.